Bio-Gene Technology
A$0.017000
0
-A$0.00-5.56% Thursday 02:26
Statistics
Day High
0.017
Day Low
0.017
52W High
0.061
52W Low
0.016
Volume
25,000
Avg. Volume
379,258
Mkt Cap
5.19M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
28AugExpected
Q2 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-2.58MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Bio-Gene Technology Limited, an agricultural technology firm based in Australia, focuses on the development and commercialization of insecticides and pesticides. These solutions are designed for a range of uses, encompassing animal health, crop protection, public health, and consumer applications. The company's key products include Flavocide, an insecticide utilizing beta-triketone technology, and Qcide, a natural oil derived from a specific cultivar of eucalyptus cloeziana. Bio-Gene maintains a research partnership with James Cook University to develop a tissue culture system, a critical step for expanding tree plantations and increasing future Qcide oil production. Furthermore, the company collaborates with BASF, the Grains Research and Development Corporation, and the Queensland Department of Agriculture and Fisheries to assess its products' effectiveness against grain storage pests. Established in 1995, Bio-Gene Technology Limited operates from its headquarters in Melbourne, Australia.
Show more...
CEO
Timothy Owen Grogan
Employees
5
Country
Australia
ISIN
AU000000BGT8
Listings
0 Comments
Share your thoughts
FAQ
What is Bio-Gene Technology stock price today?▼
The current price of BGT.AU is A$0.02 AUD — it has decreased by -5.56% in the past 24 hours. Watch Bio-Gene Technology stock price performance more closely on the chart.
What is Bio-Gene Technology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange Bio-Gene Technology stocks are traded under the ticker BGT.AU.
Is Bio-Gene Technology stock price growing?▼
BGT.AU stock has fallen by -10.53% compared to the previous week, the month change is a -26.09% fall, over the last year Bio-Gene Technology has showed a -19.05% decrease.
What is Bio-Gene Technology market cap?▼
Today Bio-Gene Technology has the market capitalization of 5.19M
When is the next Bio-Gene Technology earnings date?▼
Bio-Gene Technology is going to release the next earnings report on March 03, 2027.
What is Bio-Gene Technology revenue for the last year?▼
Bio-Gene Technology revenue for the last year amounts to 0 AUD.
What is Bio-Gene Technology net income for the last year?▼
BGT.AU net income for the last year is -2.58M AUD.
How many employees does Bio-Gene Technology have?▼
As of September 05, 2026, the company has 5 employees.
In which sector is Bio-Gene Technology located?▼
Bio-Gene Technology operates in the Materials sector.
When did Bio-Gene Technology complete a stock split?▼
The last stock split for Bio-Gene Technology was on March 06, 2018 with a ratio of 6:5.
Where is Bio-Gene Technology headquartered?▼
Bio-Gene Technology is headquartered in Melbourne, Australia.